Clinical Trial Update: Safety and Efficacy Study Comparing Pad-gauze With Anti-fibrinolytic Agent Hemostopan™) to a Regular Pad-gauze [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating Hemostopan anti-fibrinolytic with pad-gauze versus regular pad-gauze for safety and efficacy in bleeding and coagulopathy, conducted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bleeding Disorders
• Coagulopathy

Drugs mentioned

• Hemostopan

Snippet

Sponsor: Sion Microtec Ltd. | Conditions: Bleeding, Coagulopathy | Phase 2, Phase 3 | Status: UNKNOWN